| Pyridindolol, a new β-galactosidase inhibitor produced by Actinomycetes. |
T. Aoyagi; M. Kumagai; T. Hazato; M. Hamada; T. Takeuchi; H. Umezawa |
J. Antibiotics |
1975 |
28 |
558-560 |
| Structure of pyridindolol, inhibitor of β-galactosidase. |
M. Kumagai; H. Naganawa; T. Aoyagi; H.Umezawa; H. Nakamura; Y. Iitaka |
J. Antibiotics |
1975 |
28 |
876-880 |
| Isoflavone rhamunosides, inhibitors of β-galactosidase produced by Actinomycetes. |
T. Aoyagi; T. Hazato; M. Kumagai; M. Hamada; T. Takeuchi; H. Umezawa |
J. Antibiotics |
1975 |
28 |
1006-1008 |
| Inhibitory activity of pyridindolol on β-galactosidase. |
M. Kumagai; T. Aoyagi; H. Umezawa |
J. Antibiotics |
1976 |
29 |
696-703 |
| p-Hydroxyphenylacetaldoxime, an inhibitor of β-galactosidase, produced by actinomycetes. |
T. Hazato; M. Kuamgai; H. Naganawa; T. Aoyagi; H. Umezawa |
J. Antibiotics |
1979 |
32 |
91-93 |
| β-Galactosidase-inhibiting new isoflavonoids produced by actinomycetes. |
T. Hazato; H. Naganawa; M. Kumagai; T. Aoyagi; H. Umezawa |
J. Antibiotics |
1979 |
32 |
217-222 |
| Galactosialidosis (β-galactosidase-neuraminidase deficiency): a possible role of serine-thiol proteases in the degradation of β-galactosidase molecules. |
H. Sakuraba; T. Aoyagi; Y. Suzuki |
Clinica Chimica Acta |
1982 |
125 |
275-282 |
